Medtronic Acquires SPR Therapeutics for $650 Million
The acquisition adds SPR’s FDA-cleared SPRINT PNS System, a short-term percutaneous peripheral nerve stimulation (PNS) therapy, to Medtronic’s pain therapy portfolio.
The acquisition adds SPR’s FDA-cleared SPRINT PNS System, a short-term percutaneous peripheral nerve stimulation (PNS) therapy, to Medtronic’s pain therapy portfolio.
The baby’s life-saving, limb-preserving treatment, costing approximately Rs 30–35 lakh, was funded through an initiative launched by HCG Cancer Centre, Bangalore.
The partnership aims to foster research, innovation, training and capacity building in sports medicine to better support Indian athletes.
Dr. Shelden Martin of OrthoArizona performed the augmented reality-assisted shoulder replacement surgery on a patient with degenerative arthritis and rotator cuff pathology.
Johnson & Johnson’s dual energy catheter ablation platform gives physicians the flexibility to choose either radiofrequency or pulsed field energy based on patient anatomy and case complexity.
WHO calls for placing people affected by cancer at the centre of cancer control efforts
The future of obesity care will involve multidisciplinary collaboration between physicians, dieticians, fitness professionals and patient support teams, says Ajanta Pharma.
VisCardia begins RECOVER-HF trial to evaluate its VisONE Synchronized Diaphragmatic Stimulation Therapy in patients with symptomatic heart failure with reduced ejection fraction (HFrEF).
The protocol spares healthy donors from repeated stem cell collection and speeds treatment for patients awaiting a transplant.
Roche’s Elecsys IGRA TB enables fast, simple, and efficient diagnosis of tuberculosis infection and can provide results in under 24 hours.